| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c978806deb024501d8f3d1d84e476e81 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2021-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9f167727f9a1e629e3c66731a0d5ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4105536e734ad1dffb90f197855d4cca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbbe790ecdaa97ca62110d8ce19a45ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cba0647545ff1539aeffa0d1e441d2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53949b9d806f87cbd724efc4b1a41236 |
| publicationDate |
2021-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202146014-A |
| titleOfInvention |
Targeting homologous recombination: a new synthetic lethal therapeutic paradigm |
| abstract |
This application is directed to inhibitors of RAD51 represented by the following structural formula, and methods for its use, such as to treat cancer. |
| priorityDate |
2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |